Back to Bills
HOUSE-BILL 3493119th Congress

HOUSE-BILL 3493: H.R.3493 - Global Fairness in Drug Pricing Act

Introduced: May 19, 2025
Status: Referred to Committee
supported

AI-Powered Summary

Generated by AI Analysis

HOUSE-BILL 3493 aims to reduce prescription drug prices for individuals by aligning U.S. prices with those in comparably developed countries, allowing for drug importation under specific conditions. Major themes include healthcare affordability and regulatory authority, with key provisions such as most-favored-nation price targets, certification by the Secretary of Health and Human Services regarding health risks, and facilitation of direct-to-consumer purchasing programs. The bill mandates a rulemaking plan for price targets and includes a study on discriminatory practices by manufacturers. Implementation requires the Secretary's certification and the establishment of regulations to ensure compliance. Potential impacts include enhanced access to affordable medications for individuals, implications for interstate commerce, and concerns about federal overreach and antitrust laws affecting pharmaceutical companies.

Demographic Impact Analysis

AI Demographics Analysis

Summary

Overall Constitutional Implications

The bill has significant implications for individual rights, particularly in the realm of healthcare access and affordability. By reducing prescription drug prices and allowing for the importation of medications, it seeks to enhance the ability of individuals to obtain necessary treatments, which is a critical aspect of health and well-being.

Key Individual Rights

  • Right to Health Care Access
  • Due Process
  • Equal Protection

Constitutional Provisions

  • Commerce Clause
  • 14th Amendment (Equal Protection)
  • Due Process Clause

Potential Constitutional Challenges Or Support

While the bill supports the right to access affordable healthcare, there may be challenges regarding equal protection if the benefits disproportionately favor certain demographic groups. Additionally, the regulatory oversight required for drug importation could raise due process concerns if not implemented equitably.

Summary

HOUSE-BILL 3493 is designed to significantly impact individual rights related to healthcare access and affordability. By potentially lowering prescription drug prices and allowing for the importation of medications, the bill aims to improve access for individuals across various demographic groups. However, careful implementation is necessary to ensure that it does not create disparities among different populations, thereby upholding constitutional principles of equal protection and due process.

Constitutional Analysis

supported

This bill appears to align with constitutional principles. The proposed legislation operates within the established framework of constitutional authority and does not appear to conflict with fundamental rights or the separation of powers.

Analysis generated using AI-powered review of constitutional principles and legal precedents.

Take Action

Text 50409

💡 How to use:

These links will start a conversation with ResistBot. When prompted, mention H.R. 3493 to reference this bill.

Contact Your Representatives

Write to YOUR elected officials about this bill

Rate This Bill

Sign in to save a private rating for this bill and track your civic engagement over time.

Sign In Free

Policy Topics

Timeline

May 19, 2025

Bill Introduced

Current

Referred to Committee

June 12, 2026

Last Updated

Ask the Constitutional AI About This Bill

Sign in free to chat with our constitutional analysis AI about this bill — get plain-English explanations, constitutional concerns, and demographic impact estimates personalized to you.

Sign In Free to Chat